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Abstract
Urological disorders, including urinary infections, incontinence, and renal 
failure, represent a significant source of morbidity and mortality in these patients. 
Long-term mortality is associated to urological causes in approximately 33%. In 
order to prevent this complications, urologic evaluation since early childhood must 
be done. The evaluation of the degree of damage to the urinary tract and the deter-
mination of the type of neurogenic bladder involved in the spina bifida spectrum 
will be the guideline for establishing therapeutic management, which can be from 
behavioral modifications, medical management, minimally invasive therapy and, as 
a last resort, surgery. In this chapter, we will discuss the wide spectrum of urologic 
implications, a brief reminder of urinary tract physiology and the pathological 
processes involved in spina bífida, as well as long-term complications. The diagnos-
tic evaluation of urinary tract and the different therapeutic modalities according to 
the type of neurogenic bladder and age will be discussed.
Keywords: urology, urinary tract infections, chronic kidney failure, management, 
augmentation cystoplasty, intermittent bladder catheterization
1. Introduction
1.1 The bladder and manifestations associated with spina bifida
The abnormal development of the neural tube is considered the most common 
cause of neurogenic bladder dysfunction in children. Nearly all patients with myelo-
meningocele (over 90%) will have some type of bladder dysfunction (neurogenic 
bladder), and 30–40% of these children will develop some degree of renal disease 
as a long-term complication if treatment is not implemented at an early age in  
childhood. [1]
Depending on the severity of the fusion defect and its location, a variety of 
neurological deficits can be seen, with variable impact on somatic, parasympa-
thetic and sympathetic innervation of the bladder. For unclear reasons, the level 
of the lesion correlates poorly with urodynamics findings and the severity of lower 
urinary tract dysfunction. [2] This affects its ability to store and empty urine and 
can lead to chronic kidney disease by poor bladder dynamics. Urological problems, 
including urinary tract infections, incontinence, and renal failure, are a significant 
cause of morbidity and mortality. Long term mortality is associated to urological 
complications in approximately 33% of these patients. [3]
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Children with myelomeningocele also have increased risk of developing kidney 
stones. In one study, the prevalence of kidney stones was 4 percent among children 
with spinal dysraphism, compared with 0.2 percent in healthy children. Likely 
mechanisms for this predisposition to upper tract urolithiasis include immobility 
(with resultant bone resorption), bacteriuria, and urinary stasis. [4]
The bladder is a hollow muscular organ whose function is to store urine to about 
400–500 mL in adults and to void as a consequence of a consequence of a filling 
stimulus. The micturition cycle is the continuous event of storing and voiding of 
urine. Normal micturition lasts approximately 15–20 seconds, and typically the 
bladder empties seven times a day and, usually, never at night. Under normal condi-
tions, the bladder works at low pressures constantly. That means that during filling 
phase, its pressure does not exceed 10 cmH20. This condition allows the continuous 
gravitational flow of urine from the ureter to the bladder, and not vice versa. When, 
for abnormal conditions, the pressure in the bladder exceeds 40 cmH20, urine flow 
stops and flows back to the ureters, causing their dilatation, and in the long term 
alteration of kidney function, culminating in end-stage chronic kidney disease if 
not treated promptly. Chronic kidney disease is one of the most frequent causes of 
mortality in patients with spina bifida. [5]
After surgical management, walking with or without aids can be achieved in all 
patients with sacral levels and 95% with low lumbar lesions, while lower urinary 
tract (LUT) dysfunction tends to remain as large post-void residual volume, high 
voiding pressures, and urinary incontinence. In contrast, in patients with occult 
spina bifida, most cases are incidentally found during X-ray screening of low 
back pain. The vast majority is asymptomatic. Some cases are accompanied by 
lipomeningomyelocele, dermoid cyst, or thick flum terminale with minimum skin 
changes such as a dimple and focal hypertrichosis. In this scenario, LUT dysfunc-
tion may present in late childhood or in adulthood, and the severity of symptoms 
can vary, from nocturnal enuresis to urinary retention. In other words, the impact 
of the LUT will depend on the type of spinal dysraphism, whether it is a cystic or it 
is limited to an occult presentation.
The pattern of dysfunction caused by spinal dysraphism is determined by the 
site and type of lesion. Patterns are divided in three regions: the region above the 
pons, the region between the pons and the sacral cord, and the sacral cord and 
infrasacral region. Each region has particularities in bladder function. It is impor-
tant to clarify that the manifestations according to this classification are not exact 
in all cases. The presentation of the neurogenic bladder in spina bifida is unpre-
dictable. The clinical manifestations tend to present great heterogeneity. These 
mixed lesions can occur especially with lesions in close proximity of the conus 
 medullaris. [6]
A detailed description of the most frequent sites affected by spina bifida are 
explained below:
1.2 Infrapontine-suprasacral lesions
A spinal cord lesion above the lumbosacral level, depending on completeness of 
the lesion, may eliminate (complete lesions) or at least reduce (incomplete lesions) 
voluntary cerebral control of micturition leading to neurogenic detrusor overac-
tivity mediated by spinal reflex pathways. Detrusor overactivity has important 
clinical implications: reduced bladder capacity, detrusor-sphincter dyssynergia 
with post-void residual urine, incontinence, and a high intravesical pressure, 
which translates to a higher risk for chronic kidney disease. Severity of the clinical 
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manifestations will depend on a complete injury is present and the level of injury 
(the higher, the more aggressive).
1.3 Sacral-infrasacral lesions
Lesions in this site will have predominantly voiding symptoms related to a hypo-
contractile (if incomplete lesion is present) or acontractile detrusor (complete lesion). 
The clinical presentation is due to injury to the parasympathetic motor nuclei that 
innervates the detrusor muscle. Stress urinary incontinence is usually related to Onuf’s 
nucleus injury and pudendal nerve dysfunction over the striated sphincter (Figure 1).
2. Management of bladder storage and voiding symptoms
Lower urinary tract manifestations are divided into two groups: storage and 
voiding symptoms. Storage symptoms appear as an alteration in the filling phase 
of the micturition cycle. These symptoms include: increased voiding frequency, 
urgency, nocturia, urinary incontinence, and painful bladder syndrome.
Voiding symptoms appear as a difficulty during urination or prior to the onset 
of it. They include: difficulty to initiate urination, need to strain or effort to initiate 
and maintain urination, weak or intermittent urinary stream, terminal drip, dysuria 
and urgency. These symptoms result in incomplete voiding.
Figure 1. 
Patterns of bladder dysfunction caused by neurological disorders: (A) Suprapontine lesion pattern; 
(B) Infrapontine-suprasacral pattern; (C) Sacral/infrasacral lesion pattern. 
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The primary goal of treatment is to preserve upper urinary tract function, 
improve continence, and improve quality of life in these patients. [5]
2.1 Storage management
In the scenario of the neurogenic patient associated with spinal dysraphism, 
the main complaint reported by patients is urinary incontinence, accompanied or 
not by urinary infections. Urinary incontinence can be explained by several patho-
physiological mechanisms. Urodynamics is a useful tool that provides objective 
diagnostic information that allows us to know the specific cause of incontinence.
Treatment includes behavioral measures such as control of fluid intake and per-
sonal hygiene. The use of medications should always be combined with conservative 
measures. The aim of these drugs is to increase bladder capacity and decrease detru-
sor pressure. Anticholinergics (also named antimuscarinics) are the most commonly 
used drugs. Its efficacy has been demonstrated in neurogenic patients with urge uri-
nary incontinence associated with an overactive detrusor. Beta 3 agonists are another 
option that was recently introduced. The efficacy of these drugs appears to be similar 
to anticholinergics with a non-inferior safety profile. The response to these medica-
tions is evaluated with the clinical control of incontinence, as well as an improvement 
in bladder capacity objectively observed by a decrease in detrusor pressure of less 
than 40 cmH2O when having a maximum bladder capacity in urodynamics. [5, 6]
2.2 Voiding symptoms
These patients are at a higher risk of presenting high filling pressures, which 
generates vesicoureteral reflux, resulting in dilatation of the upper urinary tract 
and deterioration of renal function. Chronic retention and reflux to the upper tract 
are conditions that increase the risk of urinary infections. Management focuses 
on improving and maintaining detrusor pressure below 40 cmH2O and control of 
urinary incontinence.
The use of clean intermittent catheterization as a mechanism for bladder emptying 
is considered the treatment of choice in the vast majority of neurogenic patients with 
evidence of urine retention. This treatment aims to adequately empty the bladder and 
thereby reduce urinary infections and incontinence. The use of an indwelling transure-
thral or suprapubic catheter should be avoided due to the demonstrated risks of recur-
rent urinary tract infections, stone formation, and urethral trauma [6] (Figure 2).
Figure 2. 
Clean intermittent catheterization technique in male and female.
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In patients where a functional voiding alteration is confirmed with dysfunction 
of the relaxation of the sphincter in the emptying phase of the micturition cycle, 
they can benefit from physiotherapy and biofeedback, which consist of training to 
improve bladder-sphincter coordination during urination. [5]
3. Follow-up protocol according to age
The main priority at the moment of birth is the closure of the spinal defect, as 
neurological complications are the main cause of morbidity and mortality during 
the first year of life; followed by urological complications. Specialized treatment 
centers state that the urological management should start immediately with inter-
mittent catheterizations and anticholinergic medications due to the risk of collagen 
deposition in the bladder wall and consequent increased risk of upper urinary tract 
damage. In fact, each of the steps toward the management of this congenital disease 
are complex and the decisions may vary. [7]
3.1 Management from the moment of birth to the age of two years
A sonographic evaluation of the upper urinary tract as well as urine cultures are 
performed every 3 to 4 months. If both tests are normal, we wait until the age of 
2 years, the age expected for most children to achieve voluntary control of micturi-
tion. In case of abnormal findings during any of the sonographic evaluations or 3 or 
more positive cultures accompanied with symptomatic infections during a year or 
less are encountered, it would be necessary to perform urodynamic testing comple-
mented with a cystogram to discard any possibility of upper urinary tract damage 
due to a hostile bladder. If this is the case, it is time to start the adequate anticholin-
ergic treatment and intermittent catheterizations. [8]
If no abnormal findings during this first 2-year follow-up are seen, an expectant 
management may be allowed.
3.2 Management from the age of two years to 20 years
Expectant management is modified to active management. Treatment goals 
are as follows: a) Avoidance of renal damage, b) Preservation of continence and 
c) Treatment of symptomatic urinary infections.
The first step is the functional evaluation by urodynamics and a structural 
evaluation with a cystogram. Videourodynamics is the Gold Standard as they are 
capable of evaluating both parameters. [9] A family member should be trained to 
perform clean intermittent catheterizations, so when the patient reaches the age of 
6 years, this information should be passed onto the child to start self-intermittent 
catheterizations. We conducted a clinical trial in which we observed that intermit-
tent catheterizations with clean technique using re-sterilized catheters did not 
increase neither the risk of urinary tract infection, nor bladder bacterial  
colonization. [10]
By performing urodynamic tests, the type of functional disturbance of the 
bladder may be assessed and classified in 4 types according to the Madersbacher 
classification: [11].
Type 1: High bladder pressure. High sphincter pressure.
Type 2: High bladder pressure. Low sphincter pressure.
Type 3: Low bladder pressure. High sphincter pressure.
Type 4: Low bladder pressure. Low sphincter pressure.
Spina Bifida and Craniosynostosis - New Perspectives and Clinical Applications
6
The risk of upper urinary tract damage is higher when Madersbacher type 1 
and type 3 bladders are encountered. After identification of the bladder type, 
anticholinergic treatment should be started to normalize increased pressures. Three 
months after beginning of treatment, follow-up with a new urodynamic test is 
performed to assess the improvement of urodynamic parameters and clinical status.
The morphology of the bladder and the presence of vesicoureteral reflux (VUR) 
are assessed with a cystogram. The risk of vesicoureteral reflux in patients with 
neurogenic bladder is up to 17%. When VUR is observed, it is important to measure 
the detrusor pressure; if a pressure greater than 40 cmH20 is found, before think-
ing of any surgical treatment such as ureteral reimplantation, an attempt is made 
to decrease these pressures with conservative treatment. In case of success, a new 
evaluation is made to reassess if RUV disappeared (Figure 3) [12].
After functional and structural evaluation, proper bladder classification and 
having started initial treatment, the second stage of management is continued. 
Follow-up is made with urine cultures every 3 months, renal sonography every 
6 months and renography every 1 to 3 years. Regarding the urodynamic test, when 
the detrusor pressure is greater than 40 cmH2O, the medical treatment is modified 
and a new urodynamic test is performed 3 months after, this is done until the goal 
of detrusor pressure of less than 40 cmH2O is achieved [13].
When to perform a new urodynamic test? 1) When there is less than 90% of 
voluntary micturition control. 2) When a new morphologic or functional distur-
bance of the kidney is observed. 3) Five years after the last urodynamic study. 
During this time, the type of neurogenic bladder could be modified due to the 
morphologic changes of growth and its effect on spinal cord. [14]
3.3 Management from the age of 21 years and over
When entering this stage, the patient is more aware of the disease and is more 
organized in its management. The bladder type usually reaches a stable state, and 
it is uncommon for the neurogenic bladder type to change. If this happens, it is 
important to evaluate the possibility of having a neurological disturbance that could 
need primary treatment.
Figure 3. 
Diagnostic and therapeutic algorithm in neurogenic bladder with vesico-ureteral reflux.
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By this age, intermittent catheterizations are usually mastered by the patient and 
clinical signs that could be suspicious of active infection are well identified. Other 
topics, such as sexuality and reproduction are approached. Reproduction methods 
are informed and instructed; recommendations are given to women who wish to 
reproduce, such as folic acid intake and modifications on the route of administra-
tion of oxybutynin, from the oral to the intravesical route. [15]
On November 23rd of 1993, we founded the Spina Bifida Association in Moterrey, 
Mexico, where we presently have 1055 patients enrolled with the following 
age ranges:




A total of 472 (44.7%) patients assist with relative frequency (At least 3 con-
sultations per year). Our experience has been forged working with the everyday 
management of our patients during 26 years, assessing their progression and 
deciding which procedures are the most adequate for them.
4. Urinary tract infections, when to treat?
Patients with neurogenic bladder due to spinal dysraphism have several factors 
that potentially increase the risk of urinary tract infections, such as, vesico-ureteral 
reflux (any grade), hypertonic bladder and foreign bodies inside the bladder. 
Schlager et al. observed that 70% of patients that perform intermittent bladder 
catheterizations present asymptomatic bacteriuria 24 weeks after the beginning of 
treatment. [16]
In patients with neurogenic bladder, including those secondary to myelome-
ningocele, urinary tract infections should be considered differently from those 
without any neurofunctional disease. The presence of bacteriuria within this group 
of patients is very common and unnecessary antibiotic treatment could be given if 
there is no acknowledgment of these facts. This could lead to future complications 
that develop due to antibiotic resistance and antibiotic side effects.
In patients performing intermittent bladder catheterizations, urine culture 
results with more than 10,000 CFU/ml are considered a clinical infection only when 
one or more of the following clinical features are present: foul smell, cloudy urine, 
fever of 38°C or more and abdominal or flank pain. [17] Positive urine culture 
without other clinical features is considered as bacterial colonization and requires 
no antibiotic treatment.
When deciding which antibiotic to prescribe, it is important to consider which 
antibiotics show the highest resistance within a community, which option would be 
delivered at adequate concentrations to the urinary bladder, this depending on the 
kidney’s capacity to eliminate the active drug, and which would be more suitable to 
eliminate infection. It is important to ponder these considerations before antibiotic 
administration, as damage to the renal parenchyma may develop in a kidney already 
vulnerable to damage. [18]
Among the behavioral methods that help us in the prevention of urinary tract 
infections we include: Adequate liquid intake, maintenance of low postvoid urine 
and short time periods between intermittent catheterizations.
Intermittent bladder catheterization is a risk factor that predisposes to infection. 
There is no significant difference in the prevention of urinary tract infections when 
comparing the sterile technique with the clean technique, as well as with the use 
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of a sterile catheter compared to a reused clean catheter; furthermore, the risk of 
colonization is the same between both techniques. [19]
5. Refractory cases to medical management
The objective of neurogenic bladder management secondary to myelomeningocele 
is focused on three main objectives: 1) Decrease the risk of renal damage 2) Preserve 
urinary continence and 3) Prevent urinary infection episodes. When these objectives 
are not reached with medical management, it is necessary to take more drastic deci-
sions, otherwise, further problems regarding renal function may be encountered and 
quality of life may be affected. Such procedures include:
5.1 Neuromodulation
An attempt is made to modulate the nerve reflexes that control the bladder, 
sphincter and the pelvic floor through sacral nerve stimulation. The use of this 
technique is well documented in certain neurologically affected patients; however, 
in patients with myelomeningocele, there are controversial results due to struc-
tural abnormalities found at a sacral level, which makes this technique a lot harder. 
Evidence is still limited; however, this remains a continuous field of investigation 
(Figure 4) [20].
5.2 Augmentation cystoplasty
The aim of this procedure is to increase the bladder capacity and decrease 
elevated pressures in the urinary tract through an intestinal patch surgically fixed at 
the bladder dome. Some contraindications for these procedures are: 1) Any func-
tional or structural disturbance of the gut, 2) Disturbances of hand dexterity to 
perform intermittent catheterizations, 3) Cognitive disturbances and 4) Significant 
damage to the renal function. [21] Significant changes have been observed after 
surgery regarding bladder storage as well as a decrease in filling pressure. Some 
early complications reported in the recent literature are wound infection (4–6%) 
Figure 4. 
Sacral neuromodulation therapy for refractory cases.
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and intestinal obstruction (3–6%). The mortality rate within this group of patients 
is reported between 0 and 2.7%. Long-term complications include metabolic dis-
turbances, such as hyperchloremia (16%) and decrease in renal function in patients 
with a creatinine clearance lower than 15 ml/min (15%) or higher than 40 ml/min 
(4.1%). [22] Mucus production by the intestinal lining is estimated between 35 and 
40 gr/day, which predisposes to stone formation, infection and obstruction. After 
catheterizations, we perform intravesical irrigations with sodium bicarbonate at a 
dilution of 0.75% to reduce mucus thickness and attempt to reduce its production 
(Figures 5–7).
Perforation after bladder-gut anastomosis has been reported in 0.8–13% of 
procedures, occurring approximately 2 years after surgery, with a mortality rate 
of 25%. Risk of bladder cancer has been reported 10–20 years after surgery, and 
is believed to be caused by urinary stasis, nitrosamines, bladder stones, chronic 
inflammation of the intestinal patch and possible immune mechanisms with an 
estimated incidence of 10–20%. [23, 24]
Cystoscopy surveillance is recommended after a period of 10 years of surgery 
and in patients that develop hematuria, suprapubic pain or recurrent urinary tract 
infections.
5.3 Urinary diversion
Ileovesicostomy uses ileum as a bypass between the bladder and skin. This 
technique represents many clinical problems due to obstruction; furthermore, it 
predisposes to infections and bladder stones The Ileal conduit technique uses an 
Figure 5. 
Ileocistoplasty: a segment of ileum is remodeled and anastomosed to the bladder dome to increase the capacity 
of the bladder.
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ileum fragment which is closed at one end, both ureters are anastomosed to the 
conduit and the remaining open ileum end is connected to the abdominal wall, 
urine is collected by an external pouch. [25]
5.4 Catheter drainage
The permanent use of urinary catheters is not a good option due to the multiple 
complications that could develop. These include recurrent infections, meatal ero-
sion, traumatic hypospadias, and stone formation. However, this technique can be 
used in cases with no other alternative options. If this were the case, the possibility 
of a suprapubic tube would be the most suitable option, which presents fewer com-
plications. It is reserved only for patients with bladder emptying disturbances. This 
procedure is not recommended for patients with hyperactive neurogenic bladder, as 
urine leak surrounding the catheter entrance could appear. [26]
Figure 6. 
Colocystoplasty: a segment of colon is remodeled and amastomosed to the bladder dome. Image obtain from 
hospital Universitario “Dr. José Eleuterio González”, shared by Dr. Adrián Gutiérrez González.
Figure 7. 
Ileocecocystoplasty: Distal ileum and cecum are used to anastomose to the dome of the bladder.
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